Stephen Pyke, DIC

Stephen Pyke is the Chief Clinical Data & Digital Officer for Parexel, leading and directing the company’s patient data and AI strategies. Stephen is a statistically trained, quantitative thinker with a deep and highly strategic understanding of patient data, drug development and operational delivery.

Prior to joining Parexel, Stephen was Senior Vice President & Development Head, Digital Data & Analytics at GSK. In this role, he led the company’s efforts to rapidly deliver a tech-enabled modernization and innovation program enabling better use of clinical data as well as productivity and efficiency gains to yield a step change in clinical trial cycle acceleration. Previously, he also held a number of senior leadership roles in R&D with GSK and Pfizer.

In February 2025, Stephen was appointed to the Executive Committee for the Clinical Trials Transformation Initiative (CTTI), a collaborative enterprise informed by individuals and organizations working towards improving the quality and efficiency of clinical trials. Stephen is also on the Board of the Clinical Research Data Sharing Alliance (CRDSA), a multi-stakeholder consortium that serves the clinical data-sharing ecosystem, as well as Chair of the Association of Clinical Research Organization’s (ACRO) AI/ML Committee. During the past 20 years he has also been honored to hold Board positions with several notable professional societies and not-for-profits, including CDISC (Clinical Data Interchange Standards Consortium; Chair), RSS (Royal Statistical Society; VP) and PSI (Statisticians in the Pharmaceutical Industry; Chair). 

Stephen holds a Master in Statistics from Imperial College London and a Bachelor in Mathematics from the University of York.